- Lobbying
- actavis
Lobbying Arrangements Results for 'Actavis'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Engage with FDA and Congress regarding pharmaceutical and medical manufacturing and regarding regulatory issues. |
Actavis, Inc.
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | |||
Details Advocate regarding provisions of patent reform legislation: S.1720, Patent Transparency & Improvement Act; S.1013, Patent Abuse Reduction Act. |
Actavis, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Issues related to implementation of the FDA user fee reauthorization bill Issues related to the Inter Partes Review (IPR) process S. 344, H.R. 990, Hatch-Waxman Integrity Act of 2019 S. 340, H.R.... |
Allergan, plc (formerly known as Actavis)
|
Van Heuvelen Strategies, LLC | |||
Details Congressional oversight of drug safety |
Actavis Inc
Devlopment, Manufacture, and Sale of First-Class Generic Pharmaceuticals |
Ryan, Phillips, Utrecht & MacKinnon | |||
Details Abuse deterrent formulations Trans-Pacific Partnership (TPP) intellectual property protection and policy |
Allergan plc
|
Arent Fox LLP | |||
Details Congressional oversight of drug safety/ |
Actavis Inc
|
Ryan MacKinnon Vasapoli and Berzok LLP FKA Ryan Phillips Utrecht and MacKinnon | |||
Details Trade agreements, including the Trans-Pacific Partnership (TPP); the Transatlantic Trade and Investment Partnership (TTIP); Trade Promotion Authority (TPA); intellectual property and access to medi... |
Actavis, Inc (formerly Watson Pharmaceuticals, Inc.)
|
MFJ INTERNATIONAL | |||
Details Abuse Deterrent Formulations S. 214- Preserve Access to Affordable Generics Act, Drug patent settlements |
Actavis
|
FIERCE, ISAKOWITZ & BLALOCK | |||
Details Worked on industry concerns related to S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; S.1895, the Lower Health Care Costs Act; and S. 3129 and HR 19, the Lower Costs, More Cu... |
Allergan, Inc. (formerly Actavis, Inc.)
|
The D Major Group | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act. |
Allergan, Plc.
Allergan is a diversified global pharmaceutical company |
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Pharmaceutical distribution and supply chain security. |
Pharmaceutical Distribution Security Alliance (PDSA)
|
Leavitt Partners, LLC | |||
Details Proposals to enhance intellectual property protections to meet unmet medical needs, notably research and development of life-saving therapies; proposals to modify the Food Drug and Cosmetic Act whi... |
Allergan USA, Inc.
|
in-house lobbying |